Status:

COMPLETED

Rural PrEP Delivery

Lead Sponsor:

Michael Ohl

Collaborating Sponsors:

Gilead Sciences

Conditions:

HIV/AIDS

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The goal of this research study is to evaluate the preliminary impact of a public-health-partnered tele-pharmacist model for pre-exposure prophylaxis (PrEP) delivery in a rural state ("TelePrEP"). In ...

Detailed Description

The Iowa Department of Public Health (IDPH) and The University of Iowa (UI) have collaborated to develop a public-health-partnered tele-pharmacist model that meets these needs ("TelePrEP"). TelePrEP w...

Eligibility Criteria

Inclusion

  • Public health client in CTR-PS programs
  • Rural or small urban-dwelling residents (Iowa residence NOT residing in Polk, Linn, Scott, or Pottawattamie counties)
  • Adults (age 18+)
  • Referred by public health for PrEP based on:
  • HIV-negative by recent (\< or = 14 days) testing AND one of following
  • men sexually active with male partner(s) in the past six months, not in a monogamous partnership with a recently-tested HIV negative man, and reporting either anal sex without condoms in the past six months, any STI in past six months, or relationship with an HIV-positive partner,
  • OR
  • sexually-active heterosexual men and women not in a monogamous relationship with an HIV-negative partner and reporting either condom-less sex with partners of unknown HIV status at high risk for HIV infection, or an ongoing sexual relationship with an HIV-positive partner,
  • OR
  • intravenous drug users (IDU) injecting drugs in the past six months and reporting either sharing of drug equipment, receipt of methadone or buprenorphine treatment in the past six months, or risk of sexual acquisition.

Exclusion

  • Self-reported current PrEP use
  • Self-reported inability to access a computer, smartphone, or tablet.
  • Residence in a large urban County (i.e. Polk, Linn, Scott, Pottawattamie)
  • HIV positive status

Key Trial Info

Start Date :

February 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2019

Estimated Enrollment :

234 Patients enrolled

Trial Details

Trial ID

NCT03343223

Start Date

February 1 2018

End Date

February 28 2019

Last Update

October 29 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States, 52242